“We would prefer to see more detailed guidance coming from EFSA (European Food safety Authority),” said Bush, who is also the president of the International Probiotics Association.
He said the fact probiotic companies were in the midst of working with regulators in other jurisdictions such as Canada, the US on probiotic authentication was placing a “definite burden” on the industry.
Bush discusses how a plethora of probiotic strains presents challenges in conducting scientific trials and translating that science into the public domain.